135 related articles for article (PubMed ID: 35513121)
1. Clinical effects of off-label reduced doses of Direct Oral Anticoagulants: A systematic review and meta-analysis.
Pereira MQ; David C; Almeida AG; Brito D; Pinto FJ; Caldeira D
Int J Cardiol; 2022 Sep; 362():76-82. PubMed ID: 35513121
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses.
Briasoulis A; Gao Y; Inampudi C; Alvarez P; Asleh R; Chrischilles E; Leira EC; Vaughan-Sarrazin M
BMC Cardiovasc Disord; 2020 Feb; 20(1):42. PubMed ID: 32013886
[TBL] [Abstract][Full Text] [Related]
3. An Updated Pooled Analysis of Off-Label Under and Over-Dosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation.
Shen NN; Ferroni E; Amidei CB; Canova C; Peron V; Wang JL; Lin HW; Gu ZC
Clin Appl Thromb Hemost; 2023; 29():10760296231179439. PubMed ID: 37264798
[TBL] [Abstract][Full Text] [Related]
4. Clinical Outcomes of Off-Label Underdosing of Direct Oral Anticoagulants After Ablation for Atrial Fibrillation.
Wakamatsu Y; Nagashima K; Watanabe R; Arai M; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Hayashi H; Iwasaki YK; Shimizu W; Nakajima I; Harada T; Koyama J; Okumura K; Tokuda M; Yamane T; Tanimoto K; Momiyama Y; Nonoguchi N; Soejima K; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Yazaki Y; Satomi K; Watari Y; Okumura Y
Int Heart J; 2020 Nov; 61(6):1165-1173. PubMed ID: 33191353
[TBL] [Abstract][Full Text] [Related]
5. Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis.
Zhang XL; Zhang XW; Wang TY; Wang HW; Chen Z; Xu B; Xu W
Circ Cardiovasc Qual Outcomes; 2021 Dec; 14(12):e007971. PubMed ID: 34932377
[TBL] [Abstract][Full Text] [Related]
6. Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis.
Joosten LPT; van Maanen R; van den Dries CJ; Rutten FH; Hoes AW; Granger CB; Hemels MEW; Geersing GJ; van Doorn S
Open Heart; 2023 May; 10(1):. PubMed ID: 37169490
[TBL] [Abstract][Full Text] [Related]
7. Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis.
Shen NN; Zhang C; Hang Y; Li Z; Kong LC; Wang N; Wang JL; Gu ZC
Front Pharmacol; 2021; 12():581293. PubMed ID: 34122056
[No Abstract] [Full Text] [Related]
8. Off-label underdosed apixaban use in Asian patients with non-valvular atrial fibrillation.
Lee SR; Choi EK; Park SH; Jung JH; Han KD; Oh S; Lip GYH
Eur Heart J Cardiovasc Pharmacother; 2021 Sep; 7(5):415-423. PubMed ID: 33471125
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes of Off-Label Dosing of Direct Oral Anticoagulant Therapy Among Japanese Patients With Atrial Fibrillation Identified From the SAKURA AF Registry.
Murata N; Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Hanada S; Nomoto K; Arima K; Takahashi F; Kotani T; Ikeya Y; Fukushima S; Itoh S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
Circ J; 2019 Mar; 83(4):727-735. PubMed ID: 30726797
[TBL] [Abstract][Full Text] [Related]
11. Off-label dose direct oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation: A new evidence of Asian dose.
Xu W; Lv M; Wu T; Huang N; Zhang W; Su J; Dai H; Gu P; Huang X; Du X; Li R; Zheng Q; Lin X; Liu Y; Zhang M; Liu X; Zhu Z; Zhang J
Int J Cardiol; 2023 Jan; 371():184-190. PubMed ID: 36208678
[TBL] [Abstract][Full Text] [Related]
12. Pattern and Impact of Off-label Underdosing of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Who are Indicated for Standard Dosing.
Cho MS; Yun JE; Park JJ; Kim YJ; Lee J; Kim H; Park DW; Nam GB
Am J Cardiol; 2020 May; 125(9):1332-1338. PubMed ID: 32098658
[TBL] [Abstract][Full Text] [Related]
13. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and Safety of Off-Label Dose-Reduced Direct Oral Anticoagulants in Atrial Fibrillation.
Arbel R; Sergienko R; Hammerman A; Greenberg-Dotan S; Batat E; Avnery O; Ellis MH
Am J Med; 2019 Jul; 132(7):847-855.e3. PubMed ID: 30776320
[TBL] [Abstract][Full Text] [Related]
15. Off-label direct oral anticoagulants dosing in atrial fibrillation and venous thromboembolism is associated with higher mortality.
Aguilar F; Lo KB; Quintero EE; Torres RJ; Hung WA; Albano JC; Alviz I; Rodriguez C; Garcia MJ; Romero J; Slipczuk L
Expert Rev Cardiovasc Ther; 2021 Dec; 19(12):1119-1126. PubMed ID: 34879208
[TBL] [Abstract][Full Text] [Related]
16. Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis.
Toso E; Peyracchia M; Matta M; D'Ascenzo F; Gaita F; Kornej J; Hindricks G; Jared Bunch T; Saliba W
Int J Cardiol; 2018 Nov; 270():172-179. PubMed ID: 29945808
[TBL] [Abstract][Full Text] [Related]
17. Effect of non-recommended doses versus recommended doses of direct oral anticoagulants in atrial fibrillation patients: A meta-analysis.
Liu X; Huang M; Ye C; Xiao X; Yan C
Clin Cardiol; 2021 Apr; 44(4):472-480. PubMed ID: 33682184
[TBL] [Abstract][Full Text] [Related]
18. Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry.
Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel J; Singer DE; Peterson ED; Piccini JP;
J Am Coll Cardiol; 2016 Dec; 68(24):2597-2604. PubMed ID: 27978942
[TBL] [Abstract][Full Text] [Related]
19. Uninterrupted anticoagulation during catheter ablation for atrial fibrillation: no difference in major bleeding and stroke between direct oral anticoagulants and vitamin K antagonists in an updated meta-analysis of randomised controlled trials.
Brockmeyer M; Lin Y; Parco C; Karathanos A; Krieger T; Schulze V; Heinen Y; Bejinariu A; Müller P; Makimoto H; Kelm M; Wolff G
Acta Cardiol; 2021 May; 76(3):288-295. PubMed ID: 32056498
[TBL] [Abstract][Full Text] [Related]
20. Off-label underdosing of four individual NOACs in patients with nonvalvular atrial fibrillation: A systematic review and meta-analysis of observational studies.
Sang C; Chen J; Sun J; Lai Y; Liu X; Zhu W
Eur J Clin Invest; 2022 Oct; 52(10):e13819. PubMed ID: 35643840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
